Lexpos News

The Department of Health and Social Care (DHSC) has today (18/11/2025) confirmed the following initial list of price concessions for November 2025: Drug Pack size Price concession Co-careldopa 12.5mg/50mg tablets 90 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.26 Febuxostat 80mg tablets 28 £4.09 Fexofenadine 180mg tablets 30 £3.89 Ibandronic acid 150mg tablets 1 £18.40 Latanoprost 50micrograms/ml eye [...]

The post November 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

The UK Health Security Agency (UKHSA) has launched a Keep Antibiotics Working campaign to coincide with World AMR Awareness Week (WAAW). WAAW is a global campaign that is held annually to improve awareness and understanding of antimicrobial resistance (AMR) and encourages best practice among the public, health workers and policymakers, all who play a critical [...]

The post Keep antibiotics working campaign appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ibandronic acid 150mg tablets. Tier 2 – medium impact Date of issue: 17th November 2025 Ibandronic acid 150mg tablets, the only licensed once monthly bisphosphonate, are in limited supply until March 2026. Alendronic acid 70mg tablets and risedronate sodium 35mg tablets [...]

The post Medicine Supply Notification: Ibandronic acid 150mg tablets appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on referred back (or unpaid) items. With referred back items, pharmacy owners risk having their payments tied up until the required endorsement information is submitted to the NHS Business Services Authority (NHSBSA). Therefore, [...]

The post Funding & Reimbursement Shorts: Referred back items appeared first on Community Pharmacy England.

The UK Health Security Agency has published the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report for 2024/25. This year, the report includes data on antibiotics supplied to patients following a Pharmacy First clinical pathway consultation. This data is taken from the ePact2 antimicrobial stewardship Pharmacy First dashboard. From April 2024 to March [...]

The post Pharmacy First: ESPAUR report provides insight into antimicrobial supply from pharmacies appeared first on Community Pharmacy England.